Alphabiopharma
1 known investors
Alpha Biopharma (Chentai) is a pharmaceutical company developing innovative drugs from clinical research through commercialization. Its marketed product Zorifertinib (zolitinib hydrochloride tablets) is a next-generation EGFR TKI for first-line treatment of adults with locally advanced or metastatic EGFR-mutant non-small cell lung cancer with central nervous system metastases.
BiotechHealthtech